HLA-mismatched renal transplantation without maintenance immunosuppression

scientific article published on 01 May 2013

HLA-mismatched renal transplantation without maintenance immunosuppression is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1056/NEJMC1213779
P932PMC publication ID3760499
P698PubMed publication ID23656665

P2093author name stringDavid H Sachs
Megan Sykes
A Benedict Cosimi
Tatsuo Kawai
Immune Tolerance Network
P2860cites workHLA-mismatched renal transplantation without maintenance immunosuppressionQ33640791
Acute renal endothelial injury during marrow recovery in a cohort of combined kidney and bone marrow allografts.Q35083894
Induced immune tolerance for kidney transplantationQ35906862
Risk of renal allograft loss from recurrent glomerulonephritisQ74445034
CD154 blockade for induction of mixed chimerism and prolonged renal allograft survival in nonhuman primatesQ80444346
P433issue19
P407language of work or nameEnglishQ1860
P304page(s)1850-1852
P577publication date2013-05-01
P1433published inThe New England Journal of MedicineQ582728
P1476titleHLA-mismatched renal transplantation without maintenance immunosuppression
P478volume368

Reverse relations

cites work (P2860)
Q38694588A New Window into the Human Alloresponse
Q91819943A Second Chance at Life
Q52888768A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation.
Q35586614Advances and challenges in immunotherapy for solid organ and hematopoietic stem cell transplantation
Q41050325Anti-Interleukin-6 Promotes Allogeneic Bone Marrow Engraftment and Prolonged Graft Survival in an Irradiation-Free Murine Transplant Model
Q49968823Biomarkers of operational tolerance following kidney transplantation - The immune tolerance network studies of spontaneously tolerant kidney transplant recipients
Q38754342Cell therapeutic approaches to immunosuppression after clinical kidney transplantation
Q91786100Cellular Therapies for the Treatment of Hematological Malignancies; Swine Are an Ideal Preclinical Model
Q39215677Chimerism-based tolerance in organ transplantation: preclinical and clinical studies.
Q47388499Clinical Translation of Mesenchymal Stromal Cell Therapies in Nephrology.
Q26745435Combined Bone Marrow and Kidney Transplantation for the Induction of Specific Tolerance
Q47100613Combining Adoptive Treg Transfer with Bone Marrow Transplantation for Transplantation Tolerance
Q36279220Competitive Market Analysis of Transplant Centers and Discrepancy of Wait-Listing of Recipients for Kidney Transplantation
Q92179702Composite tissue allotransplantation: opportunities and challenges
Q89820624Cyclophosphamide-Induced Tolerance in Allogeneic Transplantation: From Basic Studies to Clinical Application
Q21284774Dendritic cell-based approaches for therapeutic immune regulation in solid-organ transplantation
Q50587076Dynamics of B Cell Recovery In Kidney/Bone Marrow Transplant Recipients.
Q64982406Early expansion of donor-specific Tregs in tolerant kidney transplant recipients.
Q26770126Emerging Implications for Extracellular Matrix-Based Technologies in Vascularized Composite Allotransplantation
Q51095965Erythropoietin Receptor-Mediated Molecular Crosstalk Promotes T Cell Immunoregulation and Transplant Survival.
Q89472835HLA in transplantation
Q61798925Hematopoietic chimerism and donor-specific skin allograft tolerance after non-genotoxic CD117 antibody-drug-conjugate conditioning in MHC-mismatched allotransplantation
Q38309290Hematopoietic stem cell infusion/transplantation for induction of allograft tolerance
Q38935186Hematopoietic stem cells and solid organ transplantation
Q90020912Human Intestinal Allografts Contain Functional Hematopoietic Stem and Progenitor Cells that Are Maintained by a Circulating Pool
Q47636630Immune Tolerance, Xenografts, and Large-Animal Studies in Transplantation
Q39314792Immune monitoring as prerequisite for transplantation tolerance trials
Q48510142Immune monitoring of transplant patients in transient mixed chimerism tolerance trials
Q38514510Immune tolerance in recipients of combined haploidentical bone marrow and kidney transplantation
Q36001563Immunomodulatory Strategies Directed Toward Tolerance of Vascularized Composite Allografts.
Q57296443Importance of Hematopoietic Mixed Chimerism for Induction of Renal Allograft Tolerance in Nonhuman Primates
Q37109198Induced regulatory T cells in allograft tolerance via transient mixed chimerism
Q39176256Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen
Q34428845Induction of macrophage-like immunosuppressive cells from mouse ES cells that contribute to prolong allogeneic graft survival
Q45074422Intragraft Molecular Pathways Associated with Tolerance Induction in Renal Transplantation.
Q37098988Kidney Versus Islet Allograft Survival After Induction of Mixed Chimerism With Combined Donor Bone Marrow Transplantation
Q36498594Longitudinal studies of a B cell-derived signature of tolerance in renal transplant recipients
Q38224758Lung transplantation: chronic allograft dysfunction and establishing immune tolerance
Q88202733Lymphodepletive effects of rabbit anti-pig thymocyte globulin in neonatal swines
Q36074384Macrochimerism in Intestinal Transplantation: Association With Lower Rejection Rates and Multivisceral Transplants, Without GVHD.
Q38725481Mesenchymal stromal cells in renal transplantation: opportunities and challenges.
Q58789294Myeloid-Derived Suppressor Cells as a Regulator of Immunity in Organ Transplantation
Q34352679Naturally acquired microchimerism: implications for transplantation outcome and novel methodologies for detection
Q46055530Nephrology research--the past, present and future
Q38614686Novel therapeutic and diagnostic management of heart transplant patients
Q39267147Operational tolerance in kidney transplantation and associated biomarkers.
Q50594543Origin of Enriched Regulatory T Cells in Patients Receiving Combined Kidney-Bone Marrow Transplantation to Induce Transplantation Tolerance.
Q49745662Orthotopic Hind Limb Transplantation in the Mouse
Q97519150Progress in Liver Transplant Tolerance and Tolerance-Inducing Cellular Therapies
Q41444299Recent Progress in Cell Therapy in Solid Organ Transplantation
Q26800184Regulatory T Cells in Kidney Transplantation: New Directions?
Q87729517Second-degree relative donors for T-replete haploidentical allogeneic stem cell transplantation with high-dose post-transplant cyclophosphamide: toward crossing the major HLA barrier
Q52570226Social, economic, and policy implications of organ preservation advances.
Q64926518Standardisation of flow cytometry for whole blood immunophenotyping of islet transplant and transplant clinical trial recipients.
Q90955751Strategies to achieve immune tolerance in allogeneic solid organ transplantation
Q38514485The role of donor-derived veto cells in nonmyeloablative haploidentical HSCT.
Q42039485Tracking donor-reactive T cells: Evidence for clonal deletion in tolerant kidney transplant patients.
Q37340107Transient mixed chimerism for allograft tolerance
Q26752512Transplant Tolerance Induction in Newborn Infants: Mechanisms, Advantages, and Potential Strategies
Q91554792Transplant research in nonhuman primates to evaluate clinically relevant immune strategies in organ transplantation
Q26751022Transplantation Tolerance Induction: Cell Therapies and Their Mechanisms
Q59400011Transplantation tolerance
Q26829817Transplantation tolerance and its outcome during infections and inflammation
Q92735518Transplantation tolerance in nonhuman primates and humans
Q34082059Transplantation tolerance: from theory to clinic
Q37677980Transplantology: Challenges for Today
Q34536503Use of CTLA4Ig for induction of mixed chimerism and renal allograft tolerance in nonhuman primates
Q34761349What's new in clinical solid organ transplantation by 2013.

Search more.